BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 11465078)

  • 1. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
    Sheweita SA
    Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.
    Shimada T
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):257-76. PubMed ID: 16946553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
    Moon YJ; Wang X; Morris ME
    Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of some hypoglycemic herbs on the activity of phase I and II drug-metabolizing enzymes in alloxan-induced diabetic rats.
    Sheweita SA; Newairy AA; Mansour HA; Yousef MI
    Toxicology; 2002 May; 174(2):131-9. PubMed ID: 11985890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the expression of cytochrome P450 2E1 and the activity of carcinogen-metabolizing enzymes in Schistosoma haematobium-infected human bladder tissues.
    Sheweita SA; Abu El-Maati MR; El-Shahat FG; Bazeed MA
    Toxicology; 2001 Apr; 162(1):43-52. PubMed ID: 11311457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.
    Shimada T
    Toxicol Res; 2017 Apr; 33(2):79-96. PubMed ID: 28443179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
    Rendic SP; Guengerich FP
    Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics.
    Schrenk D
    Biochem Pharmacol; 1998 Apr; 55(8):1155-62. PubMed ID: 9719469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of enzymes involved in metabolism of polycyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes.
    Stasiecki P; Oesch F; Bruder G; Jarasch ED; Franke WW
    Eur J Cell Biol; 1980 Apr; 21(1):79-92. PubMed ID: 6769676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes.
    Sheweita SA; Mangoura SA; el-Shemi AG
    J Helminthol; 1998 Mar; 72(1):71-7. PubMed ID: 9639905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of onion consumption by rats on hepatic drug-metabolizing enzymes.
    Teyssier C; Amiot MJ; Mondy N; Auger J; Kahane R; Siess MH
    Food Chem Toxicol; 2001 Oct; 39(10):981-7. PubMed ID: 11524136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
    Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
    Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the expression of cytochrome P450 isozymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice.
    Sheweita SA; Mubark J; Doenhofe MJ; Mostafa MH; Margison GP; O'Connor PJ; Elder RH
    J Helminthol; 2002 Mar; 76(1):71-8. PubMed ID: 12018200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
    Castell JV; Donato MT; Gómez-Lechón MJ
    Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():189-204. PubMed ID: 16092727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide spectrum detection of precarcinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome P450 isoenzymes.
    Paolini M; Sapigni E; Hrelia P; Scotti M; Morotti M; Cantelli-Forti G
    Carcinogenesis; 1991 May; 12(5):759-66. PubMed ID: 1903089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
    Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
    Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.